Moorman A V, Roman E, Cartwright R A, Morgan G J
Leukaemia Research Fund Centre for Clinical Epidemiology, University of Leeds, 30 Hyde Terrace, Leeds LS2 9LN, UK.
Br J Cancer. 2002 Jan 7;86(1):60-2. doi: 10.1038/sj.bjc.6600010.
Cytogenetically-defined subgroups of acute myeloid leukaemia have distinct biologies, clinical features and outcomes. Evidence from therapy-related leukaemia suggests that chromosomal abnormalities are also markers of exposure. Our results suggest that the smoking-associated risk for acute myeloid leukaemia is restricted to the t(8;21)(q22;q22) subgroup. This supports the hypothesis that distinct cytogenetic subgroups of acute myeloid leukaemia have separate aetiologies.
急性髓系白血病的细胞遗传学定义亚组具有不同的生物学特性、临床特征和预后。治疗相关白血病的证据表明,染色体异常也是暴露的标志物。我们的结果表明,吸烟相关的急性髓系白血病风险仅限于t(8;21)(q22;q22)亚组。这支持了急性髓系白血病不同细胞遗传学亚组具有不同病因的假说。